<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05096299</url>
  </required_header>
  <id_info>
    <org_study_id>OCS-HEART-02-PAS</org_study_id>
    <nct_id>NCT05096299</nct_id>
  </id_info>
  <brief_title>OCS Heart EXPAND + CAP Continued Follow-Up</brief_title>
  <official_title>OCS Heart EXPAND + CAP Continued Follow-Up Post-Approval Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TransMedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TransMedics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-approval observational study of subjects that were enrolled and transplanted in the OCS&#xD;
      Heart EXPAND and OCS Heart EXPAND CAP studies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 16, 2015</start_date>
  <completion_date type="Anticipated">August 2026</completion_date>
  <primary_completion_date type="Anticipated">August 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient survival</measure>
    <time_frame>5 years post transplant</time_frame>
    <description>Patient survival through 5 years post-transplant</description>
  </primary_outcome>
  <other_outcome>
    <measure>Cardiac patient survival</measure>
    <time_frame>5 years post transplant</time_frame>
    <description>Cardiac related patient survival through 5 years post-transplant</description>
  </other_outcome>
  <other_outcome>
    <measure>Graft survival</measure>
    <time_frame>5 years post transplant</time_frame>
    <description>Graft survival through 5 years post-transplant</description>
  </other_outcome>
  <enrollment type="Actual">150</enrollment>
  <condition>Heart Transplant</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCS Heart</intervention_name>
    <description>Transplanted with OCS preserved heart.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients transplanted in the OCS Heart EXPAND and EXPAND CAP trials will comprise the&#xD;
        patient population for this PAS.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients transplanted in the OCS Heart EXPAND and EXPAND CAP trials&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 15, 2021</study_first_submitted>
  <study_first_submitted_qc>October 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

